Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb<sup>®</sup>) in patients with sepsis and septic shock.

World J Crit Care Med · 2021 · PMC7805252 · PMID 33505870

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In general, there was a tendency of reduced need for vasopressors post CytoSorb ® therapy, but it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.